The Joint Corp. Announces Exercise of Over-Allotment Option
Company Added
Company Removed
Apply to Request List

The Joint Corp. Announces Exercise of Over-Allotment Option

SCOTTSDALE, Ariz., Nov. 19, 2014 // PRNewswire // -- The Joint Corp. (NASDAQ: JYNT), a national healthcare franchisor of chiropractic clinics, today announced that the underwriters of its initial public offering have exercised in full their over-allotment option to purchase an additional 450,000 shares at the initial price to the public of $6.50 per share. After giving effect to the over-allotment closing, the total number of shares sold by The Joint Corp. in its initial public offering increased to 3,450,000 shares, which resulted in aggregate net proceeds, after deducting underwriting discounts, commissions and other offering expenses, of approximately $20,000,000.

Roth Capital Partners and Feltl and Company acted as joint book-running managers for the offering. Sanders Morris Harris acted as co-manager.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on November 10, 2014. This offering was made only by means of a prospectus. Copies of the final prospectus may be obtained by contacting Roth Capital Partners, LLC, 888 San Clemente, Newport Beach, CA 92660, Attention: Equity Capital Markets, or by telephone at (800) 678-9147, or by e-mail at rothecm@roth.com; and Feltl and Company, 2100 LaSalle Plaza, 800 LaSalle Ave, Minneapolis, MN 55402, Attention: Prospectus Department, or by telephone at (612) 492 8800; or by e-mail: prospectus@feltl.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

SOURCE The Joint Corp.

###

Add to Request List

Comments:

comments powered by Disqus
Share This Page

Subscribe to our Newsletters